Pages that link to "Q34694480"

The following pages link to Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. (Q34694480):

Displaying 50 items.

• Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth (Q24200953) (← links)
• Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth (Q24244821) (← links)
• Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial (Q24622553) (← links)
• Progesterone to prevent spontaneous preterm birth (Q26827262) (← links)
• Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study (Q28069874) (← links)
• Bridging progestogens in pregnancy and pregnancy prevention (Q28082015) (← links)
• Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis (Q30844080) (← links)
• Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis (Q33886845) (← links)
• A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix (Q34119248) (← links)
• Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data (Q34143212) (← links)
• The role of progesterone in prevention of preterm birth (Q34271918) (← links)
• Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle (Q34620970) (← links)
• Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation (Q34629600) (← links)
• Progesterone use after successful treatment of threatened pre-term delivery (Q35017662) (← links)
• The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use (Q35101424) (← links)
• A novel optical method to assess cervical changes during pregnancy and use to evaluate the effects of progestins on term and preterm labor (Q35156867) (← links)
• Progestin treatment for the prevention of preterm birth (Q35223822) (← links)
• Thermosensitive progesterone hydrogel: a safe and effective new formulation for vaginal application. (Q35674138) (← links)
• Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth (Q35703067) (← links)
• Outcome of vaginal progesterone as a tocolytic agent: randomized clinical trial (Q36004789) (← links)
• Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals (Q36016724) (← links)
• Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial. (Q36095536) (← links)
• Comparative Study of Vaginal versus Intramuscular Progesterone in the Prevention of Preterm Delivery: A Randomized Clinical Trial (Q36217310) (← links)
• Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy (Q36311625) (← links)
• Inadvertent P-hacking among trials and systematic reviews of the effect of progestogens in pregnancy? A systematic review and meta-analysis. (Q36314361) (← links)
• Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birth (Q36328567) (← links)
• Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis (Q36487287) (← links)
• Care for women with prior preterm birth (Q36829111) (← links)
• Vaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: A randomized placebo-controlled double-blind study (Q37010395) (← links)
• Preterm Birth Prevention: Effects of Vaginal Progesterone Administration on Blood Flow Impedance in Uterine-Fetal Circulation by Doppler Sonography. (Q37137051) (← links)
• Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety (Q37230248) (← links)
• Progestational agents for the prevention of preterm birth (Q37322420) (← links)
• The negative regulators of the host immune response: an unexplored pathway in preterm birth. (Q37341353) (← links)
• Progesterone to prevent preterm birth in twin gestations: what is the next step forward? (Q37487072) (← links)
• Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial (Q37498149) (← links)
• The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk (Q37593578) (← links)
• Actions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth (Q37704144) (← links)
• Clinical Management of the Short Cervix (Q37875955) (← links)
• Myth: Tocolysis for prevention of preterm birth has a major role in modern obstetrics (Q37884913) (← links)
• The role of progesterone in maternal and fetal medicine (Q38051406) (← links)
• Progestogens for preterm birth prevention: a systematic review and meta-analysis by drug route. (Q38093437) (← links)
• The rebirth of progesterone in the prevention of preterm labor (Q38093767) (← links)
• Prediction of spontaneous preterm delivery in singleton pregnancies: where are we and where are we going? A review of literature (Q38198759) (← links)
• Cerclage, progesterone and α-hydroxyprogeterone caproate treatment in women at risk for preterm delivery (Q38200106) (← links)
• Synergy and interactions among biological pathways leading to preterm premature rupture of membranes (Q38212803) (← links)
• The study of progesterone action in human myometrial explants (Q38767954) (← links)
• Effectiveness of progesterone, cerclage and pessary for preventing preterm birth in singleton pregnancies: a systematic review and network meta-analysis (Q38851004) (← links)
• Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety. (Q38989189) (← links)
• Fundamentals of Clinical Pharmacology With Application for Pregnant Women (Q39302581) (← links)
• Treatment options and recommendations to reduce preterm births in women with short cervix (Q39588201) (← links)